Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 17, 2021 - Issue 6
Submit an article Journal homepage
1,856
Views
6
CrossRef citations to date
0
Altmetric
Editorial

DEL-1: a potential therapeutic target in inflammatory and autoimmune disease?

George Hajishengallisa Penn Dental Medicine, Department of Basic and Translational Sciences, University of Pennsylvania, Philadelphia, PA, USACorrespondence[email protected]
View further author information
&
Triantafyllos Chavakisb Faculty of Medicine, Institute for Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, Dresden, GermanyCorrespondence[email protected]
View further author information
Pages 549-552 | Received 15 Feb 2021, Accepted 08 Apr 2021, Published online: 19 Apr 2021

References

  • Galli SJ, Borregaard N, Wynn TA. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat Immunol. 2011;12:1035–1044.
  • Hajishengallis G, Chavakis T. DEL-1-regulated immune plasticity and inflammatory disorders. Trends Mol Med. 2019;25:444–459.
  • Choi EY, Chavakis E, Czabanka MA, et al. Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment. Science. 2008;322:1101–1104.
  • Eskan MA, Jotwani R, Abe T, et al. The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss. Nat Immunol. 2012;13:465–473.
  • Hajishengallis G, Chavakis T. Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities. Nat Rev Immunol. 2021. Online ahead of print. DOI:10.1038/s41577-020-00488-6
  • Choi EY, Lim JH, Neuwirth A, et al. Developmental endothelial locus-1 is a homeostatic factor in the central nervous system limiting neuroinflammation and demyelination. Mol Psychiatry. 2015;20:880–888.
  • Kim DY, Lee SH, Fu Y, et al. Del-1, an endogenous inhibitor of TGF-beta activation, attenuates fibrosis. Front Immunol. 2020;11:68.
  • Yan S, Chen L, Zhao Q, et al. Developmental endothelial locus-1 (Del-1) antagonizes interleukin-17-mediated allergic asthma. Immunol Cell Biol. 2018;96:526–535.
  • Li X, Colamatteo A, Kalafati L, et al. The DEL-1/β3 integrin axis promotes regulatory T cell responses during inflammation resolution. J Clin Invest. 2020;130:6261–6277.
  • Maekawa T, Hosur K, Abe T, et al. Antagonistic effects of IL-17 and D-resolvins on endothelial Del-1 expression through a GSK-3beta-C/EBPbeta pathway. Nat Commun. 2015;6:8272.
  • Consiglio CR, Cotugno N, Sardh F, et al. The immunology of multisystem inflammatory syndrome in children with COVID-19. Cell. 2020;183:968–81.e7.
  • Kourtzelis I, Li X, Mitroulis I, et al. DEL-1 promotes macrophage efferocytosis and clearance of inflammation. Nat Immunol. 2019;20:40–49.
  • Yuh DY, Maekawa T, Li X, et al. The secreted protein DEL-1 activates a β3 integrin-FAK-ERK1/2-RUNX2 pathway and promotes osteogenic differentiation and bone regeneration. J Biol Chem. 2020;295:7261–7273.
  • Shin J, Maekawa T, Abe T, et al. DEL-1 restrains osteoclastogenesis and inhibits inflammatory bone loss in nonhuman primates. Sci Transl Med. 2015;7:307ra155.
  • Chavakis T, Mitroulis I, Hajishengallis G. Hematopoietic progenitor cells as integrative hubs for adaptation to and fine-tuning of inflammation. Nat Immunol. 2019;20:802–811.
  • Mitroulis I, Chen L-S, Singh RP, et al. Secreted protein Del-1 regulates myelopoiesis in the hematopoietic stem cell niche. J Clin Invest. 2017;127:3624–3639.
  • Chen LS, Kourtzelis I, Singh RP, et al. Endothelial cell-specific overexpression of Del-1 drives expansion of haematopoietic progenitor cells in the bone marrow. Thromb Haemost. 2018;118:613–616.
  • Saxena S, Venugopal R, Chandrayan Rao R, et al. Association of chronic periodontitis and type 2 diabetes mellitus with salivary Del-1 and IL-17 levels. J Oral Biol Craniofac Res. 2020;10:529–534.
  • Folwaczny M, Karnesi E, Berger T, et al. Clinical association between chronic periodontitis and the leukocyte extravasation inhibitors developmental endothelial locus-1 and pentraxin-3. Eur J Oral Sci. 2017;125:258–264.
  • Inonu E, Kayis SA, Eskan MA, et al. Salivary Del-1, IL-17, and LFA-1 levels in periodontal health and disease. J Periodontal Res. 2020;55:511–518.
  • Lin Z, Bei JX, Shen M, et al. A genome-wide association study in Han Chinese identifies new susceptibility loci for ankylosing spondylitis. Nat Genet. 2012;44:73–77.
  • Goris A, Sawcer S, Vandenbroeck K, et al. New candidate loci for multiple sclerosis susceptibility revealed by a whole genome association screen in a Belgian population. J Neuroimmunol. 2003;143:65–69.
  • Ziogas A, Maekawa T, Wiessner JR, et al. DHEA inhibits leukocyte recruitment through regulation of the integrin antagonist DEL-1. J Immunol. 2020;204:1214–1224.
  • Maekawa T, Tamura H, Domon H, et al. Erythromycin inhibits neutrophilic inflammation and mucosal disease by upregulating DEL-1. JCI Insight. 2020;5:e136706.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.